The understanding of disease biology and therapeutics of Multiple Myeloma (MM) is rapidly evolving.

In our country, MM is managed by clinical hematologists, medical oncologists, radiation oncologists, nephrologists, orthopedicians as well as general physicians.

Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians.

Their are challenges in management which are unique to the Indian MM patients. These challenges result from a multitude of factors including differences in disease biology (late presentation), constraints in the availability of various diagnostic and therapeutic armamentaria in our country, patient tolerance to therapy, and acceptability and affordability for the same.

In an attempt to discuss these challenges and establish uniformity in managing MM patients, Myeloma State of the Art 2016 conference was organized from 30th September to 1st October 2016 at PGIMER Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/ recommendations that can be adapted to the Indian Scenario.

Keeping up with these goals the Indian Myeloma Congress was held at AHRR New Delhi from 09 Feb-11 Feb 2018 which saw the official launch of the IMAGe group along with the launch of its website.

The event also witnessed the release of two consensus guidelines on the Minimal Risk Stratification in MM & Bone health management in India. The special attraction of the event included establishment of the common software platform for entering data.